3 completed, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Terminated 1 |
Follow AT2101: new trials by email Literature Review of AT2101 trials Research Report on AT2101
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients afegostat tartrate - Gaucher Disease, Type 1 Gaucher Disease | Phase 2 | Completed | Amicus Therapeutics | 8 | 2009-05-11 | 2018-08-15 |
| A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101 AT2101 - Type 1 Gaucher Disease | Phase 1 | Terminated | Amicus Therapeutics | 1 | 2009-04-01 | 2010-08-19 |
| A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease afegostat tartrate - Gaucher Disease, Type 1 Gaucher Disease | Phase 2 | Completed | Amicus Therapeutics | 19 | 2008-06-11 | 2018-08-15 |
| A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy Afegostat tartrate - Gaucher Disease, Type 1, Type 1 Gaucher Disease | Phase 2 | Completed | Amicus Therapeutics | 30 | 2007-03-23 | 2018-09-25 |
Gaucher Disease (4)
United States (4) · United Kingdom (3) · Israel (1) · South Africa (1)